Skip to main navigation Skip to search Skip to main content

Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole

  • Andrea CALCAGNO
  • , Alice TRENTALANGE
  • , MARCO SIMIELE
  • , Letizia MARINARO
  • , FRANCESCA PATTI
  • , Maria C Tettoni
  • , Laura TRENTINI
  • , Giovanni DI PERRI
  • , ANTONIO D'AVOLIO
  • , Stefano BONORA

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)695-696
Number of pages2
JournalTherapeutic Drug Monitoring
Volume37
Issue number5
DOIs
Publication statusPublished - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-HIV Agents
  • Drug Interactions
  • HIV Infections
  • Humans
  • Liver Cirrhosis
  • Male
  • Middle Aged
  • Rilpivirine

Cite this